Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2012 Financial Results
Date:2/28/2013

,570,380)(1,398,525)Total stockholders' equity

47,018197,811Total liabilities and stockholders' equity

$
497,790$
,550(1) The consolidated balance sheet at December 31, 2011 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements.  NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share information)(Unaudited)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011Revenue:  Product sales

$  10,405$
,073$
35,399$
24,864  Royalty revenues

9083,0954,87410,327  Non-cash royalty revenue related to sale of future royalties

3,896-10,791-  License, collaboration and other

5,9376,61430,12736,289Total revenue

21,14615,78281,19171,480Operating costs and expenses:  Cost of goods sold

7,2905,45030,42821,891  Research and development

46,37333,302148,675126,766  General and administrative

10,86411,49841,61446,760  Impairment of long-lived assets

--1,675-Total operating costs and expenses

64,52750,250222,392195,417Loss from operations

(43,381)(34,468)(141,201)(123,937)Non-operating income (expense):  Interest income 

4506612,3152,244  Interest expense

(4,682)(2,525)(15,489)(10,223)  Non-cash interest expense on liability related to sale of future royalties

(5,416)-(18,057)-  Other income (expense), net

70(445)983(1,044)Total non-operating expense, net

(9,578)(2,309)(30,248)(9,023)Loss before provision for income taxes

(52,959)(36,777)(171,449)(132,960)Provision (benefit) for income taxes

(33)7184061,018Net loss

$ (52,926)$ (37,495)$ (171,855)$ (133,978)Basic and diluted
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Nektar To Host Conference Call To Discuss The Positive Phase 3 Clinical Results For Naloxegol
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
4. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
5. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
6. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
7. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
8. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
9. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Israel , February 27, 2015 /PRNewswire/ ... baut sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz ... aus -     ... Technologies, die ein neuartiges Herzüberwachungssystem für Patienten ... heute bekannt, dass sie ein Finanzierungsvorhaben über ...
(Date:2/26/2015)... -- Finesse expands office in Leicester, United Kingdom ... of its operations in Leicester , ... for customers is expected shortly afterward. With ... the current office, the new premises will double the ... Finesse to bring on more service personnel. The new ...
(Date:2/26/2015)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced that ... financial results after the market closes on Thursday, March ... will host a conference call with the investment community at ... 5, 2015 to discuss the results of the quarter ... the live conference call via telephone by dialing (877) 407-0784 ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
(Date:2/28/2015)... Heart diseases are on the rise in India. ... population and 5 percent of rural adult population suffer ... of them require specialized investigation and treatment to prevent ... (CVD). , A division of Indian Business News Agency ... “Indian Coronary Stent Market Forecast to 2019”. The new ...
(Date:2/28/2015)... Chicago, IL (PRWEB) February 28, 2015 ... growth, Chunk Fitness has added an additional exercise to ... as the oblique exercise is most commonly known as, ... equipment. , “Rope Pulls” are executed in a relatively ... varying fitness and strength levels. The full description of ...
(Date:2/28/2015)... 2015 March—also known as National ... remind ourselves and others that suspected head injuries, ... Specialists (ANS). , Concussions are a form of ... of TBIs. There are 1.6-3.8 million sports-related concussions ... but it is a brain injury. Many athletes ...
(Date:2/28/2015)... Fredericton, NB (PRWEB) February 28, 2015 ... call center software suite for Asterisk, are pleased to ... the highly successful 5.7 and 5.8 versions of Q-Suite, ... as well as a number of new features to ... be Q2 2015. , Q-Suite 5.9 will add features ...
(Date:2/28/2015)... MD (PRWEB) February 28, 2015 The ... present its annual awards at the International Symposium on ... will be held at the Hyatt Regency Bethesda in ... for their dedicated work and commitment to the mission ... the Year Award will be presented to Miriam Ratner. ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4
... New study recommends pregnant women start an exercise program , ... recommend low to moderate levels of exercise to their pregnant patients, ... report published in the August 2009 issue of the ... According to this review article, exercise can strengthen and improve ...
... ... an accident, featuring music by Jack Johnson, Ben Harper, Jason Mraz, G. Love & others ... Los Angeles, CA (PRWEB) August 3, 2009 ... will be opening the Malibu Film Festival on Thursday, August 6th at the Malibu Cinemas. "Domestix ...
... , , , ... Preventive Medicine Examines Unintended Consequences ... while a necessary and positive trend for reducing exposure to secondhand ... of the American Journal of Preventive Medicine includes a ...
... PLAINSBORO, N.J., Aug. 3 Pharmacy & Healthcare ... Director of Pharmacy Times , a monthly journal that ... 112-year-old publication as well as its website, www.PharmacyTimes.com ... direct the custom supplements, including Pharmacy Times ...
... ATLANTA, Aug. 3 Blue Cross and Blue Shield ... for the administration of the H1N1 (swine flu) vaccine when ... administration will be covered for members whose benefit plans provide ... also continue coverage of seasonal flu vaccine administration for those ...
... microscopic tubes into tumors and heating them with a quick, ... to effectively kill kidney tumors in nearly 80 percent of ... cancer treatment for humans. The study appears in the ... of Sciences ). It is the result of a collaborative ...
Cached Medicine News:Health News:Exercise Is Healthy for Mom and Child During Pregnancy 2Health News:Exercise Is Healthy for Mom and Child During Pregnancy 3Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 2Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 3Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 2Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 3Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 4Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 5Health News:Pharmacy Times Names New Editorial Director 2Health News:BCBSGA Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Researchers effectively treat tumors with use of nanotubes 2Health News:Researchers effectively treat tumors with use of nanotubes 3
... Every Bard® Biopsy Instrument and Needle ... one important goal: a large quality, reliable ... exceptional performance, featuring ultra-sharp tips and polished ... broad selection of biopsy systems and needle ...
... The SourceLink™ Delivery System offers a ... It addresses the challenges associated with ... provides the flexibility of seed and ... packaged per customers desired quantity and ...
... iQ®200 Automated Urine Microscopy Analyzer (iQ200) ... (APR®) software to classify urine particles ... results. The iQ200 eliminates most technologist ... particle images by automating specimen preparation, ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
Medicine Products: